| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |